ProQR to present AX-0810 Phase 1 data at AASLD Liver Meeting
PRQR•ProQR Therapeutics will present AX-0810 Phase 1 data on Nov. 5 and 8 at the AASLD Liver Meeting in Denver. The company also plans presentations on AX-0810 and AX-0811 at two other events in November and December 2026.
1. Upcoming presentations
ProQR Therapeutics will present AX-0810 Phase 1 data on Nov. 5 and 8 at the AASLD Liver Meeting, scheduled for Nov. 5-9, 2026, in Denver. A Nov. 3 presentation at TIDES Europe in Amsterdam will cover AX-0810 clinical findings and AX-0811 development, while a Dec. 9 event, Nature’s RNA at the Bench and Bedside V, will feature AX-0810 follow-up data and AX-0811 preclinical findings.
